The guidelines specify that to be on any GLP-1 drug, generic or the originals, a prescription from an endocrinologist, a cardiologist or an internal medicine specialist is essential
Semaglutide is one option in this category and may be considered depending on individual factors identified during the evaluation process
Eight RCTs (assessed with RoB2) had a low risk of bias across all domains, particularly in areas of outcome data completeness, and selective reporting
This technology enables extended pharmacological activity through the site-specific conjugation of a cysteine-albuminconjugated Exendin-4 analog (CA-Exendin-4) to the Fc fragment of human immunoglobulin G subclass 4 (IgG4), linked via a flexible peptide spacer (Fig
Arizona lawmakers should step in
GLP-1 agonists/analogues show beneficial effects on most of the multiple alterations underlying MASLD and cirrhosis progression [10]